Fig. 9From: Upregulation of ERK-EGR1-heparanase axis by HDAC inhibitors provides targets for rational therapeutic intervention in synovial sarcomaSchematic representation of the proposed HDACi activated auto-sustaining pro-survival loop and its blockade by co-treatment with ERK pathway and heparanase inhibitors in SS cells. This figure was prepared using tools from Servier Medical Art (http://www.servier.fr/servier-medical-art)Back to article page